APA (7th ed.) Citation

Inder, W. J., & Grossmann, M. (2023). Obesity and "functional hypogonadism"--mechanisms and management: Commentary on EJE-22-1110 "leflutrozole in male obesity-associated hypogonadotropic hypogonadism: Ph 2b double-blind RCT". European Journal of Endocrinology, 189(3), R7. https://doi.org/10.1093/ejendo/lvad100

Chicago Style (17th ed.) Citation

Inder, Warrick J., and Mathis Grossmann. "Obesity and "Functional Hypogonadism"--mechanisms and Management: Commentary on EJE-22-1110 "Leflutrozole in Male Obesity-associated Hypogonadotropic Hypogonadism: Ph 2b Double-blind RCT"." European Journal of Endocrinology 189, no. 3 (2023): R7. https://doi.org/10.1093/ejendo/lvad100.

MLA (9th ed.) Citation

Inder, Warrick J., and Mathis Grossmann. "Obesity and "Functional Hypogonadism"--mechanisms and Management: Commentary on EJE-22-1110 "Leflutrozole in Male Obesity-associated Hypogonadotropic Hypogonadism: Ph 2b Double-blind RCT"." European Journal of Endocrinology, vol. 189, no. 3, 2023, p. R7, https://doi.org/10.1093/ejendo/lvad100.